Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Winsun Pharmaceutical Co., Ltd. is a prominent Chinese enterprise specializing in the animal health industry, focusing on the research, development, and production of veterinary medicines. Established in 2002, the company operates large-scale GMP-certified manufacturing facilities in Guangzhou, producing a diverse range of products including injections, oral solutions, and premixes. Its portfolio addresses critical needs in livestock and poultry management, covering anti-infectives, anti-parasitics, and nutritional supplements. Winsun integrates modern pharmaceutical technology with traditional Chinese medicine to develop innovative treatments for animal diseases. The company serves both the domestic Chinese market and international clients, positioning itself as a key player in the global veterinary supply chain. Through its dedicated R&D efforts, Winsun continues to expand its offerings in vaccines and advanced drug delivery systems for animal care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Winsun Pharmaceutical.